These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antioxidant enzymes and survival of normal and simian virus 40-transformed mouse embryo cells after hyperthermia. Omar RA; Yano S; Kikkawa Y Cancer Res; 1987 Jul; 47(13):3473-6. PubMed ID: 3034417 [TBL] [Abstract][Full Text] [Related]
23. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Matthews N; Neale ML; Jackson SK; Stark JM Immunology; 1987 Sep; 62(1):153-5. PubMed ID: 3653925 [TBL] [Abstract][Full Text] [Related]
24. Factors influencing the oxidation of cysteamine and other thiols: implications for hyperthermic sensitization and radiation protection. Biaglow JE; Issels RW; Gerweck LE; Varnes ME; Jacobson B; Mitchell JB; Russo A Radiat Res; 1984 Nov; 100(2):298-312. PubMed ID: 6093188 [TBL] [Abstract][Full Text] [Related]
25. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Braunschweiger PG; Johnson CS; Kumar N; Ord V; Furmanski P Cancer Res; 1988 Nov; 48(21):6011-6. PubMed ID: 3262418 [TBL] [Abstract][Full Text] [Related]
26. Proliferation of mouse fibroblasts induced by 1,2-dimethylhydrazine auto-oxidation: role of iron and free radicals. Gamberini M; Leite LC Biochem Biophys Res Commun; 1997 May; 234(1):44-7. PubMed ID: 9168957 [TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Maley MA; Davies MJ; Grounds MD Exp Cell Res; 1995 Jul; 219(1):169-79. PubMed ID: 7628533 [TBL] [Abstract][Full Text] [Related]
28. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro. Sarna S; Bhola RK Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874 [TBL] [Abstract][Full Text] [Related]
29. Amphotericin B both inhibits and enhances T-cell proliferation: inhibitory effect is mediated through H(2)O(2) production via cyclooxygenase pathway by macrophages. Kumar S; Chakrabarti R J Cell Biochem; 2000 Apr; 77(3):361-71. PubMed ID: 10760945 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
31. EGF-effects in vitro and in vivo on a carcinoma cell line rich in EGFR. Torp SH; Helseth E; Unsgaard G; Dalen A Anticancer Res; 1995; 15(3):667-70. PubMed ID: 7645940 [TBL] [Abstract][Full Text] [Related]
32. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs. Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289 [TBL] [Abstract][Full Text] [Related]
33. The action of N,N-diethyldithiocarbamate(DDC) on red blood cells. Heumann C; Dumdey R; Müller M Biomed Biochim Acta; 1990; 49(2-3):S183-5. PubMed ID: 2167080 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of heat sensitivity and modification of repair of potentially lethal heat damage in plateau-phase cultures of mammalian cells by diethyldithiocarbamate. Evans RG; Nielsen J; Engel C; Wheatley C Radiat Res; 1983 Feb; 93(2):319-25. PubMed ID: 6296911 [TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones. Hayden PJ; Free KE; Chignell CF Mol Pharmacol; 1994 Jul; 46(1):186-98. PubMed ID: 8058052 [TBL] [Abstract][Full Text] [Related]
37. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system. Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272 [TBL] [Abstract][Full Text] [Related]
38. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor. Paulsen JE; Elgjo K In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236 [TBL] [Abstract][Full Text] [Related]
39. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. He GA; Luo JX; Zhang TY; Hu ZS; Wang FY Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609 [TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]